Matt Shah is the CEO and Co-Founder of OcuAI, an innovative healthtech company redefining the standard of glaucoma care through artificial intelligence. With a mission to bridge the gap between clinicians and patients to address the demand – capacity mismatch, Matt is spearheading a paradigm shift in long-term disease management. One that empowers patients with continuous, expert-guided support, regardless of geography or income and provides clinicians with the essential tools and skills to survive, reduce burnout and optimise their performance.
At OcuAI, Matt leads with a collaborative and mission-driven approach, valuing humility, precision, and curiosity. He has guided the team through iterative development of OcuAI’s AI-powered tools, focused on delivering 24/7 access to specialist education and guidance. Under his leadership, the platform will expand into new geographies while remaining grounded in a single, unwavering vision: equitable access to continuous, high-quality care, education and information.
Matt is a vocal advocate for rethinking healthcare’s triple constraint; time, energy, and space and believes AI can unlock a hybrid future where digital tools complement, not replace, human clinicians. His work at OcuAI is not only reshaping the delivery of glaucoma care but also challenging the healthcare industry to fall in love with solving the right problems.
In 2025, Matt was recognized as one of ‘THE 5 MOST INFLUENTIAL HEALTHCARE LEADERS TO FOLLOW IN 2025.’ for his leadership and vision. His journey continues to inspire others to reimagine chronic disease management with empathy, innovation, and impact.
